← FDA Drug Approvals (Drugs@FDA)

DOJOLVI

NDA · New Drug Application · Sponsor: ULTRAGENYX PHARM INC · Approved 2020-06-30

Drug application

FDA Application #

NDA213687

Application type

New Drug Application

Brand name

DOJOLVI

Generic name

TRIHEPTANOIN

Active ingredients

TRIHEPTANOIN

Dosage form

LIQUID

Route

ORAL

Marketing status

Prescription

Sponsor

ULTRAGENYX PHARM INC

Manufacturer

Ultragenyx Pharmaceutical Inc.

First approval

2020-06-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown